Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-09-030399
Filing Date
2009-06-01
Accepted
2009-06-01 19:17:52
Documents
1
Period of Report
2009-05-28

Document Format Files

Seq Description Document Type Size
1 form423306_060109191729-.html 4  
1 form423306_060109191729-.xml 4 15594
  Complete submission text file 0001144204-09-030399.txt   18401
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address BAKER BROTHERS ADVISORS 667 MADISON AVENUE NEW YORK NY 10021
Business Address
BAKER JULIAN (Reporting) CIK: 0001087939 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 09866433

Mailing Address BAKER BROTHERS ADVISORS 667 MADISON AVENUE NEW YORK NY 10021
Business Address
BAKER FELIX (Reporting) CIK: 0001087940 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 09866435

Mailing Address 667 MADISON AVENUE 17TH FLOOR NEW YORK NY 10065
Business Address 667 MADISON AVENUE 17TH FLOOR NEW YORK NY 10065 212-339-5600
Baker Brothers Life Sciences Capital (GP), LLC (Reporting) CIK: 0001307729 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 09866434